跳至主要内容
临床试验/NCT06357923
NCT06357923招募中不适用

Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance as Well as Variations and Allelic Mutations in the Main Genes Involved in the Occurrence of Age-related Myelodysplastic Syndromes

Centre Hospitalier Universitaire de Nice1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Expression level of LAMP2 (protein and isoform A and B mRNA)

研究概览

简要总结

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1.

详细描述

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1. After explanations and collection consent, collection of the patient's socio-demographic and medical characteristics and then carrying out a Peripheral venous blood sample (2 x 5ml tubes).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
60 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Men and women over 60 years of age.

排除标准

  • •Inability to Understand Consent,
  • •Non-Security Beneficiaries
  • •social, subjects protected by law, subjects deprived of liberty,
  • •history of breast cancer,
  • •brain tumor,
  • •melanoma,
  • •colon cancer,
  • •lung cancer,
  • •prostate cancer,
  • •lymphoma,
  • •syndrome myelodysplastic/myeloproliferative,
  • •leukemia,
  • •history of radiation therapy.

研究组 & 干预措施

evaluation of LAMP-2 protein expression

Other

dosing of level expression of LAMP-2

干预措施: dosage (Diagnostic Test)

结局指标

主要结局

Expression level of LAMP2 (protein and isoform A and B mRNA)

时间窗: day 0

dosage

次要结局

  • Presence of mutation in the "Oncomin Myeloid Reasearch Assay" gene panel targeting approximately 40 Different genes(day 0)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study of the Evolution of the Expression of the... | 临床试验